DBV Technologies (NASDAQ:DBVT) Price Target & New Coverage by Deutsche Bank

In a research report sent to clients and investors on 23 June, Deutsche Bank analyst just has begun coverage of Dbv Technologies (NASDAQ:DBVT) with Buy rating. The target price per share is $46.0.

The initiation is well-received by stock investors, as NASDAQ:DBVT is right now trading 2.90% higher at $36.91 as of 8:06 AM New York time. DBV Technologies’s stock is 0% in the past 200 days. It has underperformed the Standard & Poor’s 500 index, which has gained 6.00% in the same time period.

Out of 7 analysts covering DBV Technologies, 7 rate it a Buy, 0 indicate a Hold while 0 suggest a Sell. The highest target is $62.92 and the lowest is $47.7 according to Thomson/First Call. The 12-month mean target is $53.5, which means upside potential of 44.95% over the current price.

DBV Technologies (NASDAQ:DBVT) Profile

DBV Technologies SA is a France-based clinical-stage biopharmaceutical company focused on changing the field of immunotherapy by developing a technology platform called Vaskin. The Company’s therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin. It dedicates its technology to treat patients, including infants and children, suffering from severe food allergies, for whom safety is paramount, since the introduction of the offending allergen into their bloodstream can cause severe or life-threatening allergic reactions, such as anaphylactic shock.

DBV Technologies (NASDAQ:DBVT) traded up 2.90% on 23 June, hitting $36.91. A total of 245,281 shares of the company’s stock traded hands. This is up from average of 117,993 shares. DBV Technologies has a 52 week low of $27.02 and a 52 week high of $37.98. The company has a market cap of $1.77 billion and a P/E ratio of 0.

Get the latest DBV Technologies (NASDAQ:DBVT) Stock Ratings at Octafinance. Completely free access to our Analyst Ratings Database for 6000+ stocks.

The post DBV Technologies (NASDAQ:DBVT) Coverage Initiated by Deutsche Bank. The Firm’s Target Price per Share is $46.0 appeared first on Octafinance.